Pfizer Ignored Neurontin Suicide Link: Testimony

Law360, New York (June 20, 2008, 12:00 AM EDT) -- At a hearing in the consolidated class action against Pfizer Inc. over its epilepsy drug Neurontin, a neurologist has reportedly claimed that Pfizer ignored his recommendation over a decade ago that the drug carry a label warning of possible side effects of depression and aggression.

Michael R. Trimble, a neurologist at the University of London, said at a hearing Thursday in the U.S. District Court for the District of Massachusetts that he had been hired to write two confidential reports in 1995 and 1996 for a...
To view the full article, register now.



Case Information

Case Title

Harden Manufacturing Corporation v. Pfizer, Inc. et al

Case Number




Nature of Suit

Other Statutory Actions


Patti B. Saris

Date Filed

May 14, 2004


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.